0 135

Cited 6 times in

Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort

DC FieldValueLanguage
dc.contributor.author권혁문-
dc.date.accessioned2018-11-20T11:47:19Z-
dc.date.available2018-11-20T11:47:19Z-
dc.date.issued2017-
dc.identifier.issn1941-7640-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/165672-
dc.description.abstractBACKGROUND: There are limited data on the frequency of and factors associated with quantitative coronary angiography (QCA)-defined longitudinal stent deformation (LSD) in various contemporary drug-eluting stents platforms. This study sought to evaluate the predictors of LSD and its long-term clinical implication. METHODS AND RESULTS: A patient-level pooled analysis was performed with 7350 lesions in 5871 patients treated with platinum-chromium-based everolimus-eluting stent (Promus Element), cobalt-chromium-based everolimus-eluting stent (Promus/Xience V), or cobalt-chromium-based zotarolimus-eluting stent (Endeavor Resolute). QCA was performed to analyze differences of stent length between immediate post-deployment and final post-procedure. Independent factors associated with LSD were identified. Clinical outcomes at 3 years were compared between those with and without QCA-based LSD. The frequency of QCA-based LSD was 1.12% (82 cases). Nine of these cases were angiographically overt. Left main or ostial lesion, bifurcation treatment with provisional side branch stenting or ballooning, additional downstream intervention of a distal lesion, intravascular ultrasound use, and adjunctive post-dilatation were independently associated with QCA-based LSD. The type of stent was not associated with QCA-based LSD. Rates of target lesion failure were nominally higher in lesions with QCA-based LSD than in those without (8.97% versus 5.88%; hazard ratio, 1.415; 95% confidence interval, 0.631-3.175; P=0.399). CONCLUSIONS: LSD is uncommon with contemporary drug-eluting stents, regardless of the type of stent platform. LSD is mainly associated with procedural factors, especially with additional downstream procedures which require the passage of devices through the stent. Careful manipulation of poststent imaging or procedural devices is required to prevent LSD. More data are needed to clarify the impact of LSD on clinical events.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherLippincott Williams & Wilkins-
dc.relation.isPartOfCIRCULATION-CARDIOVASCULAR INTERVENTIONS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHAged, 80 and over-
dc.subject.MESHCardiovascular Agents/administration & dosage-
dc.subject.MESHChromium Alloys-
dc.subject.MESHCoronary Angiography-
dc.subject.MESHCoronary Artery Disease/diagnostic imaging-
dc.subject.MESHCoronary Artery Disease/therapy*-
dc.subject.MESHDatabases, Factual-
dc.subject.MESHDrug-Eluting Stents*-
dc.subject.MESHEverolimus/administration & dosage-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHPercutaneous Coronary Intervention/adverse effects-
dc.subject.MESHPercutaneous Coronary Intervention/instrumentation*-
dc.subject.MESHPlatinum-
dc.subject.MESHProsthesis Design-
dc.subject.MESHProsthesis Failure-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHRisk Factors-
dc.subject.MESHSirolimus/administration & dosage-
dc.subject.MESHSirolimus/analogs & derivatives-
dc.subject.MESHTime Factors-
dc.subject.MESHTreatment Outcome-
dc.subject.MESHUltrasonography, Interventional-
dc.titlePredictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort-
dc.typeArticle-
dc.contributor.college1. College of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorTae-Min Rhee-
dc.contributor.googleauthorKyung Woo Park-
dc.contributor.googleauthorJoo Myung Lee-
dc.contributor.googleauthorMichael S. Lee-
dc.contributor.googleauthorKi-Hyun Jeon-
dc.contributor.googleauthorHyun-Jae Kang-
dc.contributor.googleauthorBon-Kwon Koo-
dc.contributor.googleauthorJay Young Rhew-
dc.contributor.googleauthorKwang Soo Cha-
dc.contributor.googleauthorJang-Ho Bae-
dc.contributor.googleauthorKyoo-Rok Han-
dc.contributor.googleauthorSi-Hoon Park-
dc.contributor.googleauthorWoo-Jung Park-
dc.contributor.googleauthorSeung-Woon Rha-
dc.contributor.googleauthorSeok-Kyu Oh-
dc.contributor.googleauthorHyuck Moon Kwon-
dc.contributor.googleauthorKi-Bae Seung-
dc.contributor.googleauthorTaehoon Ahn-
dc.contributor.googleauthorSang-Hyun Kim-
dc.contributor.googleauthorHyo-Soo Kim-
dc.identifier.doi10.1161/CIRCINTERVENTIONS.117.005518-
dc.contributor.localIdA00260-
dc.relation.journalcodeJ00539-
dc.identifier.eissn1941-7632-
dc.identifier.pmid29146671-
dc.identifier.urlhttps://www.ahajournals.org/doi/full/10.1161/CIRCINTERVENTIONS.117.005518-
dc.subject.keywordcoronary angiography-
dc.subject.keyworddrug-eluting stents-
dc.subject.keywordpercutaneous coronary intervention-
dc.subject.keywordrisk factors-
dc.subject.keywordstents-
dc.contributor.alternativeNameKwon, Hyuck Moon-
dc.contributor.affiliatedAuthor권혁문-
dc.citation.volume10-
dc.citation.number11-
dc.citation.startPagee005518-
dc.identifier.bibliographicCitationCIRCULATION-CARDIOVASCULAR INTERVENTIONS, Vol.10(11) : e005518, 2017-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.